Literature DB >> 32579912

Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury.

Kevin A Guttenplan1, Benjamin K Stafford2, Rana N El-Danaf3, Drew I Adler4, Alexandra E Münch5, Maya K Weigel6, Andrew D Huberman7, Shane A Liddelow8.   

Abstract

Glaucoma is a neurodegenerative disease that features the death of retinal ganglion cells (RGCs) in the retina, often as a result of prolonged increases in intraocular pressure. We show that preventing the formation of neuroinflammatory reactive astrocytes prevents the death of RGCs normally seen in a mouse model of glaucoma. Furthermore, we show that these spared RGCs are electrophysiologically functional and thus still have potential value for the function and regeneration of the retina. Finally, we demonstrate that the death of RGCs depends on a combination of both an injury to the neurons and the presence of reactive astrocytes, suggesting a model that may explain why reactive astrocytes are toxic only in some circumstances. Altogether, these findings highlight reactive astrocytes as drivers of RGC death in a chronic neurodegenerative disease of the eye.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  astrocytes; astrogliosis; glaucoma; glia; neurodegeneration; neuroprotection; optic nerve crush; reactive astrocyte

Mesh:

Substances:

Year:  2020        PMID: 32579912      PMCID: PMC8091906          DOI: 10.1016/j.celrep.2020.107776

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  46 in total

1.  Functional circuitry of the retinal ganglion cell's nonlinear receptive field.

Authors:  J B Demb; L Haarsma; M A Freed; P Sterling
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

2.  An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex.

Authors:  Ye Zhang; Kenian Chen; Steven A Sloan; Mariko L Bennett; Anja R Scholze; Sean O'Keeffe; Hemali P Phatnani; Paolo Guarnieri; Christine Caneda; Nadine Ruderisch; Shuyun Deng; Shane A Liddelow; Chaolin Zhang; Richard Daneman; Tom Maniatis; Ben A Barres; Jian Qian Wu
Journal:  J Neurosci       Date:  2014-09-03       Impact factor: 6.167

3.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

4.  Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system.

Authors:  I Sommer; M Schachner
Journal:  Dev Biol       Date:  1981-04-30       Impact factor: 3.582

5.  An optic nerve crush injury murine model to study retinal ganglion cell survival.

Authors:  Zhongshu Tang; Shuihua Zhang; Chunsik Lee; Anil Kumar; Pachiappan Arjunan; Yang Li; Fan Zhang; Xuri Li
Journal:  J Vis Exp       Date:  2011-04-25       Impact factor: 1.355

6.  Cellular reactions at the lesion site after crushing of the rat optic nerve.

Authors:  M Frank; H Wolburg
Journal:  Glia       Date:  1996-03       Impact factor: 7.452

7.  Four alpha ganglion cell types in mouse retina: Function, structure, and molecular signatures.

Authors:  Brenna Krieger; Mu Qiao; David L Rousso; Joshua R Sanes; Markus Meister
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

8.  Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries.

Authors:  Daniel Sun; Sara Moore; Tatjana C Jakobs
Journal:  J Exp Med       Date:  2017-04-17       Impact factor: 14.307

9.  Complement 3+-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia.

Authors:  Kristin Hartmann; Diego Sepulveda-Falla; Indigo V L Rose; Charlotte Madore; Christiane Muth; Jakob Matschke; Oleg Butovsky; Shane Liddelow; Markus Glatzel; Susanne Krasemann
Journal:  Acta Neuropathol Commun       Date:  2019-05-22       Impact factor: 7.801

10.  Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration.

Authors:  Amit U Joshi; Paras S Minhas; Shane A Liddelow; Bereketeab Haileselassie; Katrin I Andreasson; Gerald W Dorn; Daria Mochly-Rosen
Journal:  Nat Neurosci       Date:  2019-09-23       Impact factor: 24.884

View more
  48 in total

Review 1.  The role of glia in the physiology and pharmacology of glucagon-like peptide-1: implications for obesity, diabetes, neurodegeneration and glaucoma.

Authors:  Qi N Cui; Lauren M Stein; Samantha M Fortin; Matthew R Hayes
Journal:  Br J Pharmacol       Date:  2021-11-23       Impact factor: 8.739

2.  Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma.

Authors:  Jacob Sterling; Peiying Hua; Joshua L Dunaief; Qi N Cui; Brian L VanderBeek
Journal:  Br J Ophthalmol       Date:  2021-08-19       Impact factor: 4.638

3.  Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation.

Authors:  Marjan Gharagozloo; Matthew D Smith; Jing Jin; Thomas Garton; Michelle Taylor; Alyssa Chao; Keya Meyers; Michael D Kornberg; Donald J Zack; Joan Ohayon; Brent A Calabresi; Daniel S Reich; Charles G Eberhart; Carlos A Pardo; Claudia Kemper; Katharine A Whartenby; Peter A Calabresi
Journal:  Acta Neuropathol       Date:  2021-09-06       Impact factor: 17.088

4.  The Chx10-Traf3 Knockout Mouse as a Viable Model to Study Neuronal Immune Regulation.

Authors:  Jami M Gurley; Grzegorz B Gmyrek; Elizabeth A Hargis; Gail A Bishop; Daniel J J Carr; Michael H Elliott
Journal:  Cells       Date:  2021-08-12       Impact factor: 7.666

5.  Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's disease.

Authors:  Eduardo R Zimmer; Pedro Rosa-Neto; Tharick A Pascoal; João Pedro Ferrari-Souza; Pâmela C L Ferreira; Bruna Bellaver; Cécile Tissot; Yi-Ting Wang; Douglas T Leffa; Wagner S Brum; Andréa L Benedet; Nicholas J Ashton; Marco Antônio De Bastiani; Andréia Rocha; Joseph Therriault; Firoza Z Lussier; Mira Chamoun; Stijn Servaes; Gleb Bezgin; Min Su Kang; Jenna Stevenson; Nesrine Rahmouni; Vanessa Pallen; Nina Margherita Poltronetti; William E Klunk; Dana L Tudorascu; Ann D Cohen; Victor L Villemagne; Serge Gauthier; Kaj Blennow; Henrik Zetterberg; Diogo O Souza; Thomas K Karikari
Journal:  Mol Psychiatry       Date:  2022-08-10       Impact factor: 13.437

Review 6.  Multifactorial Pathogenic Processes of Retinal Ganglion Cell Degeneration in Glaucoma towards Multi-Target Strategies for Broader Treatment Effects.

Authors:  Gülgün Tezel
Journal:  Cells       Date:  2021-06-02       Impact factor: 6.600

Review 7.  Astrocyte Networks as Therapeutic Targets in Glaucomatous Neurodegeneration.

Authors:  Andrew M Boal; Michael L Risner; Melissa L Cooper; Lauren K Wareham; David J Calkins
Journal:  Cells       Date:  2021-06-02       Impact factor: 6.600

Review 8.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

9.  Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes.

Authors:  Jiwen Li; Lin Pan; William G Pembroke; Jessica E Rexach; Marlesa I Godoy; Michael C Condro; Alvaro G Alvarado; Mineli Harteni; Yen-Wei Chen; Linsey Stiles; Angela Y Chen; Ina B Wanner; Xia Yang; Steven A Goldman; Daniel H Geschwind; Harley I Kornblum; Ye Zhang
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 17.694

10.  The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissues associated with glaucoma pathogenesis.

Authors:  Chad A Sundberg; Monika Lakk; Sharan Paul; Karla P Figueroa; Daniel R Scoles; Stefan M Pulst; David Križaj
Journal:  J Comp Neurol       Date:  2021-08-18       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.